Terms: = Endocrine gland cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
39 results:
1. Prevalence and Incidence of Fractures in Patients With Nonfunctional Adrenal Tumors.
Lindh JD; Patrova J; Mannheimer B; Falhammar H
JAMA Netw Open; 2024 Apr; 7(4):e246453. PubMed ID: 38619841
[TBL] [Abstract] [Full Text] [Related]
2. Germline Genetic Testing After cancer Diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Factors and treatment Impact on Overall Survival in Adult Craniopharyngioma.
Awad M; Butterfield JT; Dhawan S; Tyler MA; Venteicher AS
World Neurosurg; 2023 May; 173():e132-e139. PubMed ID: 36773809
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasound-based Nomogram for Predicting the Pathological Nodal Negativity of Unilateral Clinical N1a Papillary Thyroid Carcinoma in Adolescents and Young Adults.
Wei Y; Sun P; Chang C; Tong Y
Acad Radiol; 2023 Sep; 30(9):2000-2009. PubMed ID: 36609031
[TBL] [Abstract] [Full Text] [Related]
5. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes and Trends of treatments in High-Risk Differentiated Thyroid cancer.
Abiri A; Goshtasbi K; Torabi SJ; Kuan EC; Armstrong WB; Tjoa T; Haidar YM
Otolaryngol Head Neck Surg; 2023 Apr; 168(4):745-753. PubMed ID: 35471863
[TBL] [Abstract] [Full Text] [Related]
7. Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer.
Leung JH; Lang HC; Wang SY; Lo HF; Chan AL
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):489-496. PubMed ID: 34241562
[TBL] [Abstract] [Full Text] [Related]
8. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Sep; 15(9):2491-2503. PubMed ID: 33690968
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
Wu D; Wang X; Shi G; Sun H; Ge G
Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
[TBL] [Abstract] [Full Text] [Related]
10. Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer.
Nakano S; Komatsu Y; Kawamoto Y; Saito R; Ito K; Nakatsumi H; Yuki S; Sakamoto N
Medicine (Baltimore); 2020 Sep; 99(39):e22250. PubMed ID: 32991420
[TBL] [Abstract] [Full Text] [Related]
11. Risks of Second Primary Gynecologic cancers following Ovarian cancer treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract] [Full Text] [Related]
12. GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity.
Barabutis N; Akhter MS; Uddin MA; Kubra KT; Schally AV
Horm Metab Res; 2020 May; 52(5):336-339. PubMed ID: 32403147
[TBL] [Abstract] [Full Text] [Related]
13. Interval debulking surgery is not worth the wait: a National cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy.
Lyons YA; Reyes HD; McDonald ME; Newtson A; Devor E; Bender DP; Goodheart MJ; Gonzalez Bosquet J
Int J Gynecol Cancer; 2020 Jun; 30(6):845-852. PubMed ID: 32341114
[TBL] [Abstract] [Full Text] [Related]
14. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
[TBL] [Abstract] [Full Text] [Related]
15. Changes in serum thyroglobulin and antithyroglobulin shortly following high-intensity focused ablation of benign thyroid nodules in patients with positive antithyroglobulin status.
Lang BHH; Woo YC; Chiu KW
Int J Hyperthermia; 2018; 35(1):637-643. PubMed ID: 30303432
[TBL] [Abstract] [Full Text] [Related]
16. Effects of chemoradiotherapy and chemotherapy on survival of patients with locally advanced pancreatic cancer: A meta-analysis of randomized controlled trials.
Wang C; Liu X; Wang X; Wang Y; Cha N
Medicine (Baltimore); 2018 Sep; 97(36):e12260. PubMed ID: 30200163
[TBL] [Abstract] [Full Text] [Related]
17. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient
Gomes-Lima CJ; Wu D; Kharazi PH; Khojekar GJ; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2017 Dec; 27(12):1558-1565. PubMed ID: 29132255
[TBL] [Abstract] [Full Text] [Related]
18. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Alistar A; Morris BB; Desnoyer R; Klepin HD; Hosseinzadeh K; Clark C; Cameron A; Leyendecker J; D'Agostino R; Topaloglu U; Boteju LW; Boteju AR; Shorr R; Zachar Z; Bingham PM; Ahmed T; Crane S; Shah R; Migliano JJ; Pardee TS; Miller L; Hawkins G; Jin G; Zhang W; Pasche B
Lancet Oncol; 2017 Jun; 18(6):770-778. PubMed ID: 28495639
[TBL] [Abstract] [Full Text] [Related]
19. A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer.
Bouchard-Fortier G; Rosen B; Vyarvelska I; Pasetka M; Covens A; Gien LT; Kupets R; Pulman K; Ferguson SE; Vicus D
Gynecol Oncol; 2016 Jan; 140(1):36-41. PubMed ID: 26546964
[TBL] [Abstract] [Full Text] [Related]
20. Radiotherapy did not increase thyroid cancer risk among women with breast cancer: A nationwide population-based cohort study.
Sun LM; Lin CL; Liang JA; Huang WS; Kao CH
Int J Cancer; 2015 Dec; 137(12):2896-903. PubMed ID: 26135015
[TBL] [Abstract] [Full Text] [Related]
[Next]
